🔎 Trials Near Me

Akèy › Osteyosakòm › Distrik Columbia › Washington

Etid klinik pou Osteyosakòm nan Washington, DC

6 etid pou Osteyosakòm ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Ap rekriteFaz 2
  • Children's National Medical Center, Washington D.C.
Laj 12 a 39 · Tout sèks · Mizajou Sep 29, 2026 · NCT04616560

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Ap rekriteFaz 3
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Jiska laj 50 · Tout sèks · Mizajou Aug 25, 2026 · NCT05235165

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

Ap rekriteFaz 1/2
  • National Institutes of Health, Bethesda · 7 mi lwen
Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Ap rekriteFaz 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Ap rekriteFaz 2
  • Children's National Medical Center, Washington D.C.
18 Months – 40 Years · Tout sèks · Mizajou Aug 12, 2025 · NCT05135975

Etid Osteyosakòm nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.